跳至主要内容
临床试验/EUCTR2006-001156-12-FI
EUCTR2006-001156-12-FI
进行中(未招募)
不适用

Corneal penetration of timolol into the human aqueous humor after administration of 0.1% Timosan eye gel or 0.5% timolol eye drops

Santen Oy0 个研究点目标入组 44 人开始时间: 2006年3月30日最近更新:

概览

阶段
不适用
状态
进行中(未招募)
发起方
Santen Oy
入组人数
44

概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients of any race and either sex meeting all of the following criteria will be considered eligible for this study. The patients should
  • 1\.be 55\-80 years
  • 2\.be in good general health
  • 3\.be scheduled for cataract surgery
  • 4\.provide a written informed consent
  • Are the trial subjects under 18?
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes

排除标准

  • Patients with any of the following conditions are not eligible for participation in this study:
  • 1\. patients with one sighted eye only
  • 2\. patients who have glaucoma
  • 3\. patients with previous surgical operation in the eye
  • 4\. known hypersensitivity to timolol or any component of the study medication, including the preservative benzalkonium chloride
  • 5\. use of any topical or systemic medication that could interfere with study medication
  • 6\. any corneal disorders
  • 7\. an active uveitis
  • 8\. heart rate \< 50/min
  • 9\. contraindications to timolol treatment:

研究者

发起方
Santen Oy

相似试验